Investing.com - Amarin (NASDAQ:AMRN) reported on Thursday third quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Amarin announced earnings per share of $0.01 on revenue of $156.5M. Analysts polled by Investing.com anticipated EPS of $0.01 on revenue of $154.63M.
Amarin shares are down 76.73% from the beginning of the year, still down 80.90% from its 52 week high of $26.12 set on December 16, 2019. They are under-performing the Nasdaq which is up 29.18% from the start of the year.
Amarin follows other major Healthcare sector earnings this month
Amarin's report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on October 27 with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.71 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar